Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$34.33−1.76 (-4.88%)
Close on Nov 13, 2026Market cap $1.91BP/E –Yield –
Maze Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Maze Therapeutics's total assets was $511.56M at Sep 30, 2026. For fiscal 2025 it was $397.13M, up 65.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $397.13M | +65.1% |
| FY2024 | Dec 31, 2024 | $240.54M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $511.56M | +21.2% |
| Q2 FY2026 | Jun 30, 2026 | $531.63M | +75.2% |
| Q1 FY2026 | Mar 31, 2026 | $419.71M | +26.1% |
| Q4 FY2025 | Dec 31, 2025 | $397.13M | +65.1% |
| Q3 FY2025 | Sep 30, 2025 | $422.06M | – |
| Q2 FY2025 | Jun 30, 2025 | $303.52M | – |
| Q1 FY2025 | Mar 31, 2025 | $332.84M | – |
| Q4 FY2024 | Dec 31, 2024 | $240.54M | – |
See a number that looks wrong?